A randomized, controlled trial comparing the immunogenecity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in kidney transplant recipients

Mari Eriksson, Helena Käyhty, Heikki Saha, Mika Lahdenkari, Petri Koskinen, Heikki Mäkisalo, Veli-Jukka Anttila

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number13343
JournalTransplant Infectious Disease
Volume22
Issue number4
Number of pages12
ISSN1398-2273
DOIs
Publication statusPublished - Aug 2020
MoE publication typeA1 Journal article-refereed

Fields of Science

  • dialysis
  • kidney transplant recipient
  • pneumococcal disease
  • pneumococcal vaccination
  • SOLID-ORGAN TRANSPLANT
  • CLINICAL-PRACTICE GUIDELINE
  • RENAL-TRANSPLANT
  • ANTIBODY-RESPONSE
  • STREPTOCOCCUS-PNEUMONIAE
  • DOUBLE-BLIND
  • IMMUNOGENICITY
  • IMMUNIZATION
  • HEMODIALYSIS
  • VACCINES
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this